RCW 69.04.014
"Immediate container."
The term "immediate container" does not include package liners.
[ 1945 c 257 § 15; Rem. Supp. 1945 § 6163-64.]
Structure Revised Code of Washington
Title 69 - Food, Drugs, Cosmetics, and Poisons
Chapter 69.04 - Intrastate Commerce in Drugs and Cosmetics.
69.04.001 - Statement of purpose.
69.04.003 - "Federal act" defined.
69.04.004 - "Intrastate commerce."
69.04.012 - "Official compendium."
69.04.014 - "Immediate container."
69.04.016 - "Misleading labeling or advertisement," how determined.
69.04.017 - "Antiseptic" as germicide.
69.04.018 - "New drug" defined.
69.04.020 - "Contaminated with filth."
69.04.050 - Remedy by injunction.
69.04.060 - Criminal penalty for violations.
69.04.070 - Additional penalty.
69.04.080 - Avoidance of penalty.
69.04.090 - Liability of disseminator of advertisement.
69.04.100 - Condemnation of adulterated or misbranded article.
69.04.110 - Embargo of articles.
69.04.120 - Procedure on embargo.
69.04.130 - Petitions may be consolidated.
69.04.140 - Claimant entitled to sample.
69.04.150 - Damages not recoverable if probable cause existed.
69.04.170 - Minor infractions.
69.04.180 - Proceedings to be in name of state.
69.04.370 - Right of access for inspection.
69.04.410 - Drugs—Adulteration by harmful substances.
69.04.420 - Drugs—Adulteration for failure to comply with compendium standard.
69.04.430 - Drugs—Adulteration for lack of represented purity or quality.
69.04.440 - Drugs—Adulteration by admixture or substitution of ingredients.
69.04.450 - Drugs—Misbranding by false labeling.
69.04.460 - Packaged drugs—Misbranding.
69.04.470 - Drugs—Misbranding by lack of prominent label.
69.04.480 - Drugs—Misbranding for failure to state content of habit forming drug.
69.04.490 - Drugs—Misbranding by failure to show usual name and ingredients.
69.04.500 - Drugs—Misbranding by failure to give directions for use and warnings.
69.04.510 - Drugs—Misbranding for improper packaging and labeling.
69.04.520 - Drugs—Misbranding for failure to show possibility of deterioration.
69.04.530 - Drugs—Misbranding by misleading representation.
69.04.540 - Drugs—Misbranding by sale without prescription of drug requiring it.
69.04.550 - Drugs exempt if in transit for completion purposes.
69.04.560 - Dispensing of certain drugs exempt.
69.04.565 - DMSO (dimethyl sulfoxide) authorized.
69.04.570 - Introduction of new drug.
69.04.580 - Application for introduction.
69.04.590 - Effective date of application.
69.04.600 - Denial of application.
69.04.610 - Revocation of denial.
69.04.620 - Service of order of denial.
69.04.630 - Drug for investigational use exempt.
69.04.640 - Court review of denial.
69.04.650 - Dispensing of certain drugs exempt.
69.04.660 - Federally licensed drugs exempt.
69.04.670 - Cosmetics—Adulteration by injurious substances.
69.04.680 - Cosmetics—Misbranding by false label, etc.
69.04.690 - Cosmetics—Misbranding by lack of prominent label.
69.04.700 - Cosmetics exempt if in transit for completion purposes.
69.04.710 - Advertisement, when deemed false.
69.04.720 - Advertising of cure of certain diseases deemed false.
69.04.730 - Enforcement, where vested—Regulations.
69.04.740 - Regulations to conform with federal regulations.
69.04.761 - Hearing on proposed regulation—Procedure.
69.04.770 - Review on petition prior to effective date.
69.04.780 - Investigations—Samples—Right of entry—Verified statements.
69.04.790 - Owner may obtain part of sample.
69.04.800 - Access to records of other agencies.
69.04.810 - Access to records of intrastate carriers.
69.04.820 - Right of entry to factories, warehouses, vehicles, etc.
69.04.830 - Publication of reports of judgments, orders and decrees.
69.04.840 - Dissemination of information.
69.04.850 - Construction—1945 c 257.